AC106876.2 | Uncharacterized protein | | | | | | Group enriched |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | Mitochondrial proteins
| | | | | Group enriched |
AMN | Amnion associated transmembrane protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AQP8 | Aquaporin 8 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ARL14 | ADP-ribosylation factor-like 14 | | | | | | Group enriched |
ATOH1 | Atonal homolog 1 (Drosophila) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Group enriched |
BCL2L15 | BCL2-like 15 | | | | | | Group enriched |
BEST2 | Bestrophin 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | | | | Group enriched |
BTNL3 | Butyrophilin-like 3 | Predicted membrane proteins
| | | | | Group enriched |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | | | | Group enriched |
C12orf36 | Chromosome 12 open reading frame 36 | | | | | | Group enriched |
C21orf88 | Chromosome 21 open reading frame 88 | | | | | | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
CAPN13 | Calpain 13 | Enzymes
| | | | | Group enriched |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Group enriched |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDX1 | Caudal type homeobox 1 | Transcription factors
| | | | | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CEACAM7 | Carcinoembryonic antigen-related cell adhesion molecule 7 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CHP2 | Calcineurin-like EF-hand protein 2 | Cancer-related genes
| | | | | Group enriched |
CHST5 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CLCA1 | Chloride channel accessory 1 | Predicted secreted proteins
| | | | | Group enriched |
CLCA4 | Chloride channel accessory 4 | Predicted membrane proteins
| | | | | Group enriched |
CLRN3 | Clarin 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
DHRS11 | Dehydrogenase/reductase (SDR family) member 11 | | | | | | Group enriched |
EPS8L3 | EPS8-like 3 | | | | | | Group enriched |
ERN2 | Endoplasmic reticulum to nucleus signaling 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FFAR4 | Free fatty acid receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FOXA3 | Forkhead box A3 | Transcription factors
| | | | | Group enriched |
FSIP2 | Fibrous sheath interacting protein 2 | | | | | | Group enriched |
GAL3ST2 | Galactose-3-O-sulfotransferase 2 | Predicted secreted proteins
| | | | | Group enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
GPA33 | Glycoprotein A33 (transmembrane) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GUCA2B | Guanylate cyclase activator 2B (uroguanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GUCY2C | Guanylate cyclase 2C (heat stable enterotoxin receptor) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
HHLA2 | HERV-H LTR-associating 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
HOXD13 | Homeobox D13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
IHH | Indian hedgehog | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |